Last reviewed · How we verify

NCT03727503: Capstesia

Casptesia Versus PICCO in Cardiac Surgical Patients in the ICU

Terminated NA Last updated 29 January 2020
What this trial tests

NA trial testing PPV from the capstesia in Surgery in 60 participants. Terminated before completion.

Timeline
27 March 2019
Primary endpoint
1 January 2020
1 January 2020

Quick facts

Lead sponsorErasme University Hospital
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment60
Start date27 March 2019
Primary completion1 January 2020
Estimated completion1 January 2020
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Erasme University Hospital

Who can join

18 and older, any sex, with Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to assess the ability of a new smartphone PPV app to predict fluid responsiveness in cardiac surgical patients in the Intensive care unit (in the postoperative period)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other Erasme University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03727503.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing